Amgen Inc (AMGN) stock news · P/E 27, rev $36.75B
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
This AMGN news page leads with what Amgen Inc filed — not a scraped headline mill.
No cached 8-K sentence for AMGN yet. We will not pad this page with generic market recap.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 27.0.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AMGN stock page; for the tape open the quote page.
AMGN stock news FAQ
What are AMGN's latest revenue and net income?
Latest cached Amgen Inc (AMGN) revenue for Dec 31, 2025 was $36.75B. Net income was $7.71B. Statements: https://lician.com/financials/amgn
How did AMGN revenue change from the prior cached period?
Cached Amgen Inc (AMGN) revenue was up 10.0% from $33.42B (Dec 31, 2024) to $36.75B (Dec 31, 2025). Statements: https://lician.com/financials/amgn
What is AMGN's P/E ratio?
Amgen Inc (AMGN) trailing P/E is 27.0 on the latest cached fundamentals snapshot.
What is AMGN's market cap?
Amgen Inc (AMGN) market cap is $188.67B on the latest cached fundamentals snapshot.
What kind of company is AMGN?
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Where is AMGN stock news listed?
Cached stock news for Amgen Inc (AMGN) is listed at https://lician.com/news/amgn. Filings: https://lician.com/sec/amgn
Not investment advice.